Treace Medical Concepts Studies of Procedures to Treat Mid-Foot Deformities Show Positive Results

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Treace Medical Concepts Studies of Procedures to Treat Mid-Foot Deformities Show Positive Results

, MT Newswires - 3:23 PM ET 3/28/2025 default

03:23 PM EDT, 03/28/2025 (MT Newswires) -- Treace Medical Concepts ( TMCI ) said Friday its interim data from clinical trials of lapiplasty and adductoplasty to treat bunions and related mid-foot deformities showed low recurrence and continued improvement in pain.

Clinical study data of the two studies of lapiplasty procedure showed a return to protected weight bearing at an average of 7.9 and 8.4 days with recorded pain improvement at 12 months and 48 months.

Data from the study of adductoplasty procedure showed return to protected weight bearing at an average of 7.5 days with recorded pain improvement at 12 months.

The company presented the interim data at the 2025 American College of Foot and Ankle Surgeons Annual Meeting in Phoenix, Arizona.

Price: 8.50, Change: +0.13, Percent Change: +1.55

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.